Department of Bio-Health Convergence, Kangwon National University, Chuncheon 24341, Korea.
Department of Herbal Medicine Resource, Kangwon National University, 346 Hwangjo-gil, Dogye-eup, Samcheok-si 25949, Gangwon-do, Korea.
Int J Mol Sci. 2021 Mar 10;22(6):2792. doi: 10.3390/ijms22062792.
Recently, nano- and micro-particulate systems have been widely utilized to deliver pharmaceutical compounds to achieve enhanced therapeutic effects and reduced side effects. Poly (DL-lactide-co-glycolide) (PLGA), as one of the biodegradable polyesters, has been widely used to fabricate particulate systems because of advantages including controlled and sustained release, biodegradability, and biocompatibility. However, PLGA is known for low encapsulation efficiency (%) and insufficient controlled release of water-soluble drugs. It would result in fluctuation in the plasma levels and unexpected side effects of drugs. Therefore, the purpose of this work was to develop microcapsules loaded with alginate-coated chitosan that can increase the encapsulation efficiency of the hydrophilic drug while exhibiting a controlled and sustained release profile with reduced initial burst release. The encapsulation of nanoparticles in PLGA microcapsules was done by the emulsion solvent evaporation method. The encapsulation of nanoparticles in PLGA microcapsules was confirmed by scanning electron microscopy and confocal microscopy. The release profile of hydrophilic drugs can further be altered by the chitosan coating. The chitosan coating onto alginate exhibited a less initial burst release and sustained release of the hydrophilic drug. In addition, the encapsulation of alginate nanoparticles and alginate nanoparticles coated with chitosan in PLGA microcapsules was shown to enhance the encapsulation efficiency of a hydrophilic drug. Based on the results, this delivery system could be a promising platform for the high encapsulation efficiency and sustained release with reduced initial burst release of the hydrophilic drug.
最近,纳米和微颗粒系统被广泛用于递药以实现增强的治疗效果和降低副作用。聚(DL-丙交酯-co-乙交酯)(PLGA)作为一种可生物降解的聚酯之一,由于具有控制和持续释放、生物降解性和生物相容性等优点,已被广泛用于制备颗粒系统。然而,PLGA 因其低包封效率(%)和水溶性药物的控制释放不足而闻名。这将导致药物的血浆水平波动和意想不到的副作用。因此,本工作的目的是开发载有藻酸盐包被壳聚糖的微胶囊,以提高亲水性药物的包封效率,同时表现出控制和持续释放的特征,减少初始突释。通过乳化溶剂蒸发法将纳米颗粒包封在 PLGA 微胶囊中。通过扫描电子显微镜和共聚焦显微镜证实了纳米颗粒在 PLGA 微胶囊中的包封。壳聚糖包被可以进一步改变亲水性药物的释放曲线。藻酸盐上的壳聚糖包被表现出较低的初始突释和亲水性药物的持续释放。此外,将藻酸盐纳米颗粒和藻酸盐纳米颗粒包被壳聚糖包封在 PLGA 微胶囊中被证明可以提高亲水性药物的包封效率。基于这些结果,该递药系统可能是一种有前途的平台,可以实现亲水性药物的高包封效率和持续释放,减少初始突释。